November 27, 2014 5:48 AM ET

Biotechnology

Company Overview of GenPharm International, L.L.C

Company Overview

GenPharm International, Inc. engages in the development and application of HuMAb-Mouse transgenic animal technology. Its technology is used in the creation of human monoclonal antibodies for therapeutic uses. The company was founded in 1989 and is based in San Jose, California. As of October 21, 1997, GenPharm International, Inc. was a subsidiary of Medarex, Inc. Later, it operates as a subsidiary of Bristol-Myers Squibb Company.

2350 Qume Drive

San Jose, CA 95131

United States

Founded in 1989

Phone:

408-526-1290

Fax:

408-955-9002

Key Executives for GenPharm International, L.L.C

Chief Executive Officer
Age: 60
Founder
Age: 70
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Schepens Eye Research Institute Inc. United States
AutoGenomics, Inc. United States
Principia Biopharma Inc. United States
EyeCyte, Inc. United States
The GI Company, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GenPharm International, L.L.C, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.